Pfizer and BioNTech planning for FDA approval for COVID-19 vaccine
Pfizer and BioNTech apply for emergency use authorization of their potential coronavirus (COVID-19) vaccine with the FDA. The Food and Drug Administration will process the request over the next couple of weeks with a scheduled advisory committee meeting to review the vaccine.
The COVID-19 vaccine by Pfizer and BioNTech has proven to prevent 95 percent of cases in initial studies and there is already a distribution plan if the FDA approves the COVID-19 vaccine. If the FDA approves this vaccine production initially be limited and rolled out in phases.
#COVID19 UPDATE: We will submit a request today to the @US_FDA for Emergency Use Authorization (EUA) of our mRNA vaccine candidate with @BioNTech_Group.
— Pfizer Inc. (@pfizer) November 20, 2020
The vaccine will be available starting with healthcare workers and the elderly with underlying health conditions will be the next phase of people to receive the vaccine. The following groups to receive the vaccine will be essential workers, teachers, people in homeless shelters, prisons, and children.
The late-stage trial of the COVID-19 vaccine involved more than 43,000 participants with the results of 170 confirmed COVID-19 infections. The study concluded that 162 infection cases were observed in the placebo group and the remaining eight cases were in the study group that received the two-dose vaccine.
Though the results of the studies are promising the storage conditions for the vaccine could prove a problem in widespread distribution. The vaccine requires special refrigeration of minus 94 °F and the competition vaccine by Moderna can be stored easily at minus 4°F.
The U.S. agreed to buy 100 million doses of the Pfizer and BioNTech vaccine that is apart of Operation Warp Speed for $1.95 billion in July. If approved, the vaccine would be on track to produce 50 million doses this year and nearly 1.3 billion doses for 2021.
We are submitting our first request for an #EUA in the U.S. for vaccine candidate #BNT162b2 against #covid19. We look forward to continuously providing data to various regulatory authorities as part of our rolling review process – including the @EMA_News. https://t.co/Lk7MTlwE5R pic.twitter.com/OjZ2IxiU3a
— BioNTech SE (@BioNTech_Group) November 20, 2020
This vaccine is also submitting proposals for regulatory agencies around the world including the Medicines & Healthcare Products Regulatory Agency in the United Kingdom and the European Medicines Agency. The leading disease expert in America, Dr. Anthony Fauci, believes the vaccine should be available to all Americans by April or July.
-
Former President Donald Trump Leaves Republicans Speculating on His Debate Strategy Former President Donald Trump has definitively confirmed that...
-
The recent incident involving U.S. soldier Travis King, who crossed from South Korea into North Korea, has garnered significant...
-
The U.S. President assures support and aid as island grapples with Deadly wildfires and recovery challenges US President Joe...
-
Tragedy unfolds as FBI confronts man over alleged threats against President Biden An incident unfolding on Wednesday shocked the...
-
Protecting the Process in Trump’s January 6 Case In the federal courthouse of Washington, DC, security measures surrounding the...
-
A New York Times/Siena College poll reveals surprising results A recent New York Times/Siena College poll reveals an intriguing...
-
Phoenix, Arizona, experienced a record-breaking stretch of scorching temperatures above 110F (43.3C) that finally came to an end yesterday...
-
Ron DeSantis Defends Florida’s New Slavery Curriculum Ron DeSantis, the Governor of Florida, recently defended introducing new education standards...
-
A Heartfelt Farewell to Tafari Campbell Over the weekend, a somber atmosphere enveloped Martha’s Vineyard as news spread about...
-
Caught on Camera: Hunter Biden’s “Sugar Brother” Lawyer in Bong Scandal In a recent incident, Kevin Morris, a prominent...
-
Breaking the Chains: Biden Administration Erases $39 Billion in Student Loan Debt. In a move aimed at providing much-needed...
-
Controversial Claims: Robert F. Kennedy Jr. Faces Backlash Over Covid Conspiracy Theories Robert F. Kennedy Jr.’s recent conspiracy-filled tirade...